Grants for State governments - Health

This funding opportunity supports research projects that develop and test innovative interventions for individuals with substance use disorders involved in the criminal justice system, particularly focusing on improving treatment access and outcomes in diverse settings.

This grant provides funding for research on how climate change impacts cancer prevention, treatment, and survivorship, targeting a wide range of organizations including governments, universities, and nonprofits.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for research on diabetes, its complications, and related endocrine and metabolic diseases. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. This NOFO will utilize the P30 activity code. Details of the planned NOFO are provided below.

The "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes" grant aims to fund research projects that prepare for clinical trials in rare diseases by developing effective strategies for testing potential treatments or diagnostics, improving success rates with robust biomarkers and assessment measures, or by understanding the progression of a rare disease to better design future clinical trials.

This funding opportunity provides financial support to a variety of organizations to strengthen Ghana's public health system, focusing on improving disease prevention, detection, and response capabilities.

This funding opportunity supports research projects that advance the use of genomic information in clinical care, particularly for diverse and underserved populations, by providing financial assistance to a range of eligible organizations.

This grant provides funding for innovative research aimed at understanding the biological and immunological factors that contribute to the increased susceptibility of transgender individuals to HIV and other sexually transmitted infections.

The Minnesota Pollution Control Agency is offering a grant of over $1 million to public, private, and nonprofit owners of heavy-duty diesel vehicles in Minnesota to replace their old vehicles with new, cleaner models, aiming to reduce diesel emissions and improve air quality.

The purpose of this notice of funding opportunity (NOFO) is to invite applications for Research Centers (RC) to support the Centers for Research in Emerging Infectious Diseases (CREID) Network. The CREID network serves to expand knowledge on re-emerging and emerging infectious diseases (re/EIDs) around the globe where outbreaks are most likely to occur. Multi- and inter-disciplinary teams of domestic and international investigators will conduct innovative, collaborative One Health (approach that recognizes the health of humans is interconnected with that of animal health and the shared environment) based research projects and will mount a rapid and effective research response to outbreaks through coordination, collaboration, and cooperation across the CREID Network.

This funding opportunity provides financial support for researchers and organizations to develop and validate innovative technologies that improve the understanding and treatment of cancer, with a focus on addressing unmet needs and health disparities.

This funding opportunity provides financial support to various organizations and governments to develop and implement trauma-informed services for children affected by violence in their homes, schools, and communities.

The National Cancer Institute intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for pilot/exploratory research on the confluence of cancer stigma and HIV stigma in HIV-positive individuals diagnosed with cancer. This NOFO will utilize the R21 grant mechanism (clinical trial optional), which is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Up to three (3) R21 awards are expected to be funded as part of the initiative. Research projects will advance the current understanding of the confluence of cancer stigma and HIV stigma in people with HIV (PWH) diagnosed with cancer; investigate the resultant impact of these dual stigmas on cancer outcomes among PWH with cancer; and promote research in diverse domestic and international contexts, focusing on regions in which the HIV-cancer burden is elevated. Pilot interventional research, which addresses modifiable mechanisms of stigma that contribute to negative cancer outcomes among PWH with cancer, is also suitable for this funding mechanism. The NOFO is expected to be published in late Summer 2024 with an expected application due date in late Fall 2024. Details of a pre-application webinar will be announced after the publication of the NOFO. This Notice is being provided to allow sufficient time for potential applicants with relevant expertise and insights to consider applying for this NOFO. Potential applicants are encouraged to view the presentation of this initiative to the Joint Virtual Meeting of the NCI Board of Scientific Advisors and the National Cancer Advisory Board available at https://videocast.nih.gov/watch=54859 beginning at 3 hour, 39 minutes. Presentation slides are downloadable at: https://deainfo.nci.nih.gov/advisory/joint/0624/Vanderpool.pdf.

This funding opportunity supports U.S. colleges and universities in developing programs that enhance diversity and provide research training for undergraduate students from underrepresented groups, preparing them for advanced biomedical research careers.

USAID/DRCs vision for Kitumaini is a five-year long activity that will focus on service deliveryresults in five (5) health zones in Haut-Katanga, with possible expansion to other provinces asguided by Office of the Global AIDS Coordinator (OGAC)/PEPFAR. This activity also intends tostrengthen the capacity of local sub-recipients to enhance their capabilities to receive assistanceawards from USAID through transition award(s). This service delivery and capacity buildingactivity will include all aspects of HIV epidemic control. Activities will take place in health zonesassigned to USAID/DRC. This service delivery activity will prioritize services that focus on prioritypopulations, orphans and vulnerable children (OVC) and key populations (KP). The recipient willcoordinate with other implementing partners to facilitate the transition of the existing KPprogram, Meeting Targets and Maintaining Epidemic Control (EpiC) to Kitumaini.

HRSA-25-002, HRSA-25-003, and HRSA-25-004 announces the opportunity to apply for funding under Ryan White HIV/AIDS Program (RWHAP) Part C Early Intervention Services (EIS) Program: Existing Geographic Service Areas. The purpose of this program is to provide comprehensive primary health care and support services in an outpatient setting for low-income people with HIV. Under this announcement, successful applicants must provide: (1) counseling for individuals with respect to HIV; (2) targeted HIV testing; (3) periodic medical evaluations of individuals with HIV and clinical and diagnostic services for HIV care and treatment; (4) therapeutic measures for preventing and treating the deterioration of the immune system, and for preventing and treating conditions arising from HIV; and (5) referrals for people with HIV to appropriate providers of health care and support services. These services are to be provided directly or through referrals, contracts, or memoranda of understanding (MOUs). This competition is open to current RWHAP Part C EIS recipients and new organizations proposing to provide RWHAP Part C EIS funded services in the geographic service areas listed in Appendix C. Please note that there are 3 funding announcement numbers included in this document with 3 different periods of performance (See Appendix C). If you are applying for more than one service area, you must submit a separate application for each proposed service area. All allowable services must relate to HIV diagnosis, care, and support, and must adhere to established HIV clinical practice standards consistent with U.S. Department of Health and Human Services (HHS) Guidelines. Please refer to the HIV/AIDS Bureau (HAB) Policy Clarification Notice (PCN) 16-02 Ryan White HIV/AIDS Program Services for a list of RWHAP allowable core medical and support services and their descriptions. According to the RWHAP Part C statute: At least 50 percent of the amount received under the award must be expended on EIS costs (except counseling and referrals/linkage to care); At least 75 percent of the award (after reserving amounts for administrative costs, planning/evaluation, and clinical quality management (CQM)) must be expended on core medical services costs (Please note: EIS is a subset of this 75 percent of the award) and; Not more than 10 percent of the total RWHAP Part C award funds can be expended on administrative costs. Applicants seeking a waiver to the core medical services requirement must submit a waiver request with this application as Attachment 15. For more details, see Program Requirements and Expectations.

This funding opportunity supports innovative research on how environmental toxicants impact RNA modifications and their role in health issues, targeting universities, nonprofits, and for-profit organizations involved in related studies.

The Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) is a funding opportunity designed to support early-stage physicians and health professionals who are committed to aging and aging-related diseases research, helping them to enhance their research and leadership skills, establish independent research programs, and prepare to lead in their field to improve health outcomes for older individuals.

This funding opportunity provides financial support to organizations working in Botswana to strengthen laboratory and health systems for effective management of HIV and TB programs.

About the Fund The Dane G. Hansen Foundation of Logan, KS, partners with the Greater Salina Community Foundation (GSCF) and the Greater Northwest Kansas Community Foundation (GNWKCF) to help improve the quality of life for communities in 26 counties of Northwest Kansas. GSCF and 11 of its affiliate foundations are allocated funding for grants to distribute to 14 counties for charitable projects through a competitive application process. What do the funds support? Grants will be awarded to projects or programs that address the following areas: Education: Enhances the learning environment and expands opportunities for students. Provides increased self-reliance on personal life skills and workforce capability. Health Care: Ensures access to quality health services and promotes healthy life practices. Community Social Services & Security: Enhance access to social services needed for individuals of special needs and supports systems to provide community disaster relief and general community emergencies. Conservation & Environment: Support efforts to improve and maintain high air and water quality, appreciation for our natural environment and enhances economic and social benefits of outdoor resources. Arts & Culture: Provide cultural and artistic opportunities to enhance the quality of life for local residents and to encourage tourism and the exchange of ideas. Community Beautification: Support efforts to improve and maintain public spaces to enhance community pride and encourage socialization among residents. Preference will be given to applications that include community involvement and volunteerism. Grants may not be awarded to: reduce or replace regular budgetary needs for programs or projects that are tax-supported support endowment or operational expenses Grant renewed every year. Grant Spring annual opening/ closing deadline: March 15th to May 15th

This grant provides funding for researchers and institutions to develop advanced tissue-engineered models that better mimic cancer biology, aiming to improve understanding and treatment of various cancer types.